Gufic Biosciences Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Gufic Biosciences Ltd. is a leading pharmaceutical company that specializes in the development, manufacturing, and marketing of a wide range of healthcare products. With a strong presence in both domestic and international markets, Gufic Biosciences is recognized for its high-quality offerings and its commitment to innovative healthcare solutions.

Established in [year], Gufic Biosciences has emerged as a trusted name in the pharmaceutical industry. The company operates across various therapeutic segments, including pain management, diabetes care, cardiology, dermatology, and more. Gufic Biosciences' products are manufactured at state-of-the-art facilities that adhere to international quality standards.

Share Price Analysis - Gufic Biosciences Ltd.

The share price of Gufic Biosciences Ltd. reflects the market perception and investors' confidence in the company's growth potential. Investors can track the share price through various platforms, including our website, where we provide real-time stock prices and historical data.

Our pre-built screening tools allow investors to analyze and compare the share price of Gufic Biosciences against industry peers, helping them make informed investment decisions. These tools provide insights into historical trends, price movements, and market performance.

Balance Sheet Analysis - Gufic Biosciences Ltd.

The balance sheet of Gufic Biosciences Ltd. provides a snapshot of the company's financial position at a given point in time. It reflects the assets, liabilities, and shareholders' equity of the company. Investors can access the company's balance sheet on our website, where we provide downloadable annual reports.

For long-term investors looking for stock analysis, our premium features offer fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help investors assess the financial health and intrinsic value of Gufic Biosciences.

Annual Report Analysis - Gufic Biosciences Ltd.

The annual report of Gufic Biosciences is a comprehensive document that provides detailed information about the company's operations, financial performance, and future outlook. It contains key financial statements, management discussions, and analysis of risks and opportunities.

As a long-term investor, it is crucial to review the annual report to gain insights into the company's strategy, competitive positioning, and growth prospects. At our website, we provide downloadable annual reports of Gufic Biosciences, allowing investors to analyze the company's performance in detail.

Dividend Analysis - Gufic Biosciences Ltd.

Dividends play an essential role in long-term investments, as they reflect the company's ability to generate profits and return value to shareholders. Gufic Biosciences has a track record of consistently rewarding its shareholders through dividends.

Investors can assess the dividend history and dividend yield of Gufic Biosciences using our pre-built screening tools. These tools provide an overview of the company's dividend payouts, helping investors make informed decisions based on their income requirements and investment objectives.

Quarterly Result Analysis - Gufic Biosciences Ltd.

The quarterly results of Gufic Biosciences provide an update on the company's financial performance and its ability to meet its targets. Investors can access the quarterly results on our website, where we provide downloadable financial statements and reports.

Our premium features enable investors to perform in-depth analysis of the quarterly results using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools assist investors in understanding the key drivers behind the company's financial performance and its future growth prospects.

Stock Price Analysis - Gufic Biosciences Ltd.

The stock price of Gufic Biosciences is influenced by various factors, including market dynamics, industry trends, company performance, and investor sentiment. Investors can track the stock price through our website, where we provide real-time data and detailed price charts.

Additionally, our pre-built screening tools allow investors to analyze and compare the stock price of Gufic Biosciences against industry peers. These tools provide insights into historical trends, price movements, and market performance, aiding investors in their decision-making process.

News Analysis - Gufic Biosciences Ltd.

Keeping up with the latest news and updates about Gufic Biosciences is essential for long-term investors. Our website provides a dedicated news section where investors can access the latest announcements, press releases, and industry updates related to Gufic Biosciences.

Staying informed about the company's developments, product launches, collaborations, and regulatory updates can help investors make well-informed investment decisions. Our website serves as a reliable source of news and information for investors interested in Gufic Biosciences.

Concall Transcripts Analysis - Gufic Biosciences Ltd.

The concall transcripts of Gufic Biosciences provide valuable insights into the company's performance, strategy, and future outlook. Investors can access the concall transcripts on our website, where we provide downloadable transcripts of the company's earnings calls.

Reviewing the concall transcripts helps investors understand management's perspective and their plans to drive future growth. These transcripts serve as a valuable resource for long-term investors seeking a deeper understanding of Gufic Biosciences' business operations.

Investor Presentations Analysis - Gufic Biosciences Ltd.

Gufic Biosciences regularly conducts investor presentations to showcase its achievements, growth plans, and future prospects. These presentations provide detailed information about the company's business model, product portfolio, and market opportunities.

Investors can access these investor presentations on our website, where we provide downloadable copies. Reviewing these presentations can help investors gain valuable insights into Gufic Biosciences' strategic initiatives, competitive advantages, and potential investment opportunities.

Promoters and Shareholders Analysis - Gufic Biosciences Ltd.

Gufic Biosciences has a strong base of promoters and shareholders who have played a vital role in the company's success. Understanding the key stakeholders and their holdings can provide insights into the confidence placed in Gufic Biosciences by industry experts and institutional investors.

While we do not provide specific details of individual promoters and shareholders, our website offers resources that help investors understand the ownership structure and the influence of key stakeholders on Gufic Biosciences' decision-making processes.

In conclusion, Gufic Biosciences Ltd. is a reputable pharmaceutical company that offers innovative healthcare products. Investors interested in long-term stock analysis can utilize our website for comprehensive insights into the company's profile, share price, balance sheet, annual reports, dividend history, quarterly results, stock price, news updates, concall transcripts, investor presentations, and key stakeholders. Our pre-built screening tools and premium features enable investors to perform in-depth analysis and fair value calculations, assisting in informed investment decision-making. 

Gufic Biosciences Balance Sheet Overview

Gufic Biosciences' Growing Equity Reserves

From March 2020 to March 2024, Gufic Biosciences has shown a significant increase in its total reserves, jumping from Rs 119.63 Cr in March 2020 to Rs 522.53 Cr by March 2024. This growth indicates a solid reinforcement of the company's equity base, reflecting its enhanced financial strength and capability to sustain and expand its operations.

Gufic Biosciences' Debt Profile

The debt profile of Gufic Biosciences has seen dynamic changes over the past few years. Borrowings peaked at Rs 190.68 Cr in March 2023 before reducing to Rs 153.96 Cr by March 2024. This fluctuation in borrowing reflects the company's debt management strategy and its response to changing financial requirements and market conditions.

Gufic Biosciences' Asset Growth

Asset growth is a crucial indicator of a company's financial health and operational expansion. Gufic Biosciences' total assets have shown a remarkable increase from Rs 406.88 Cr in March 2020 to Rs 1,092.54 Cr by March 2024. Significant investments in capital work-in-progress (WIP) from Rs 30.61 Cr in March 2020 to Rs 307.06 Cr by March 2024, highlight the company's focus on expanding its operational capabilities and future growth prospects.

Analysis for the Standalone Balance Sheet of the Company

In addition to the detailed balance sheet analysis, investors and stakeholders closely monitor stock performance, market indices, and the company's sectoral dynamics for informed decision-making.